Literature DB >> 17434766

Abnormal permeability pathways in human red blood cells.

J C Ellory1, H C Robinson, J A Browning, G W Stewart, K A Gehl, J S Gibson.   

Abstract

A number of situations that result in abnormal permeability pathways in human red blood cells (RBCs) have been investigated. In sickle cell disease (SCD), RBCs contain HbS, rather than the normal HbA. When deoxygenated, an abnormal conductance pathway, termed P(sickle), is activated, which contributes to cell dehydration, largely through allowing Ca(2+) entry and subsequent activation of the Gardos channel. Whole-cell patch-clamp recordings from sickle RBCs show a deoxygenated-induced conductance, absent from normal RBCs, which shares some of the properties of P(sickle): equivalent Na(+) and K(+) permeability, significant Ca(2+) conductance, partial inhibition by DIDS and also Zn(2+). Gd(3+) markedly attenuates conductance in both normal and sickle RBCs. In addition, deoxygenated sickle cells, but not oxygenated ones or normal RBCs regardless of the oxygen tension, undergo haemolysis in isosmotic non-electrolyte solutions. Non-electrolyte entry was confirmed radioisotopically whilst haemolysis was inhibited by DIDS. These findings suggest that under certain circumstances P(sickle) may also be permeable to non-electrolytes. Finally, RBCs from certain patients with hereditary stomatocytosis have a mutated band 3, which appears able to act as a conductance pathway for univalent cations. These results extend our understanding of the abnormal permeability pathways of RBCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434766     DOI: 10.1016/j.bcmd.2007.02.011

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  5 in total

1.  Cryohydrocytosis: increased activity of cation carriers in red cells from a patient with a band 3 mutation.

Authors:  Anna Bogdanova; Jeroen S Goede; Erwin Weiss; Nikolay Bogdanov; Poul Bennekou; Ingolf Bernhardt; Hans U Lutz
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

2.  The hereditary stomatocytoses.

Authors:  Joanna F Flatt; Lesley J Bruce
Journal:  Haematologica       Date:  2009-08       Impact factor: 9.941

3.  Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.

Authors:  Panae Noomuna; Mary Risinger; Sitong Zhou; Katie Seu; Yuncheng Man; Ran An; Daniel A Sheik; Jiandi Wan; Jane A Little; Umut A Gurkan; Francesco M Turrini; Theodosia Kalfa; Philip S Low
Journal:  Br J Haematol       Date:  2020-04-28       Impact factor: 6.998

Review 4.  Determinants of erythrocyte hydration.

Authors:  Jesse Rinehart; Erol E Gulcicek; Clinton H Joiner; Richard P Lifton; Patrick G Gallagher
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

5.  Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening.

Authors:  Panae Noomuna; John M Hausman; Ruhani Sansoya; Theodosia Kalfa; Mary Risinger; Philip S Low
Journal:  FASEB J       Date:  2022-06       Impact factor: 5.834

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.